Clinical Trials

1 studies in Primary Systemic Amyloidosis

1. Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation Rochester, MN View Summary
   Close

   Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation

   Location:

   Rochester, MN

   Trial status:

   Open for Enrollment

   Why is this study being done?

   1. How does age at diagnosis affect prognosis in primary amyloidosis? 2. How do lab values at diagnosis such as Creatinine, AST/ALT, total serum protein, serum gamma globulin/immunoglobulin levels affect prognosis in primary amyloidosis? 3. How does degree of organ involvement/number of organs involved affect prognosis in primary amyloidosis? 4. How does initial treatment affect prognosis in primary amyloidosis? 4. How do the specifics the stem cell transplant protocol affect prognosis in primary amyloidosis?

   NCT ID:

   NCT01606280

   IRB Number:

   11-005003

   • Print Summary
   • View study details

   Who can I contact for additional information about this study?

   Rochester: Moire Gertz, MD 507-284-3725
                       
   
   
   

   Request Information Online